Gold prices are on track to rally to all-time highs in 2024 on the back of tapering interest rates. U.S. core CPI increased 0.2% for the second straight month, the first time since February 2021.
Gold prices are on track to rally to all-time highs in 2024 on the back of tapering interest rates. U.S. core CPI increased 0.2% for the second straight month, the first time since February 2021.
Other recent economic data has shown signs of a cooling labour market. Recent data showed the U.S. economy added 187,000 jobs in July, the fewest since December 2020.
Spot gold prices hit its intra-day record of 2,072.5 in 2020 and some analysts believe the precious metal will hit a new high beyond that level.
Gold will rise above 2,100 in late 2023 or early 2024 as the Fed has almost won its inflation fight, said Bart Melek, TD Securities’ managing director and global head of commodity strategy.
UOB also forecasts that gold prices will set new records, but only by the second half of 2024, predicting that gold will trade at $2,100 per ounce then.
Markets are currently pricing in a 90% chance that Fed maintains its benchmark interest rate in a range of 5.25%-5.50% in September, the CME FedWatch Tool showed.
Chinese retail gold demand has been resilient in 2023 even as consumption of other commodities remained weak, Citi said in a July report.
Citi projects more than 700 ton of jewelry demand, up 22% from the same period last year, from China this year. central bank purchases of gold have also been strong, especially from BRICS countries.
Disclaimer: Investment involves risk. The content of this article is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product.
Procter & Gamble leads in consumer goods with diverse brands and innovation. Its stock has seen a 1.673% increase since 1990. showing stable growth.
2024-09-06The capital adequacy ratio measures a bank's financial health and risk tolerance. A high ratio boosts stability, but too high may reduce efficiency.
2024-09-06Johnson & Johnson leads in healthcare with strong finances. The stock is near fair value, offering a good entry point despite market risks.
2024-08-30